on Drägerwerk AG & Co. KGaA (ETR:DRW8)
Drägerwerk AG & Co. KGaA Reports Stable Sales and Increased Orders in H1 2025
Drägerwerk AG & Co. KGaA reported a positive EBIT of EUR 20 million for the first half of 2025, despite being below the previous year's figure of EUR 55.8 million due to one-off gains in 2024. The EBIT margin was 1.3%, down from 3.7% in 2024. Net sales remained nearly stable at EUR 1,510 million, with the medical division seeing a 1.8% rise. However, the safety division experienced a 1.4% decline.
Order intake grew significantly by 10.1% to EUR 1,738 million, marking the highest level since the first half of 2020. This growth was driven by substantial increases in both the medical and safety divisions, with the former seeing a major multi-year order from Mexico.
The company maintained its forecast for the year, expecting net sales growth of 1.0 to 5.0% and an EBIT margin between 3.5 and 6.5%. Full results for the first half will be revealed on July 29, 2025.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Drägerwerk AG & Co. KGaA news